Indokem growth over the years

Compounded a year1 yr2 yr
Revenue−3.7%+3.0%
EBITDA−23.9%—
Net Income+131.7%—
EPS (adj.)+131.7%—
Total Assets+3.1%+6.5%
Total Equity+4.0%+2.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDOKEM₹643.30

Indokem Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASGRAUWEILJYOTIRESKANCHIMcap ₹1,780 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue-3.7+3.0
EBITDA-23.9—
Net Income+131.7—
EPS (adj.)+131.7—
Total Assets+3.1+6.5
Total Equity+4.0+2.7
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.